Dr. David Kendall: From Lilly Diabetes to Leading MannKind ' s Afrezza Research
DiabetesMine interviews the former Chief Medical Officer of Eli Lilly Diabetes who has recently joined Afrezza inhaled insulin maker MannKind.
Source: Diabetes Mine - Category: Endocrinology Authors: Mike Hoskins Source Type: blogs